Larimar Therapeutics (LRMR) Financials

$3.85

$-0.02 (-0.52%)

As on 10-Sep-2026 16:00EDT

Market cap

$398 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.09	0.35	0.32	0.31	0.27	0.33
Gross Profit	-0.09	-0.35	-0.32	-0.31	-0.27	-0.33
Operating Expenses	178.99	172.50	90.89	41.76	36.53	50.47
Operating Profit (EBIT)	-178.99	-172.50	-90.89	-41.76	-36.53	-50.47
Other Income	--	--	--	--	1.17	--
Profit before Tax	-172.61	-165.67	-80.60	-36.95	-35.36	-50.64
Provision for Tax	--	--	--	--	-1.17	-0.33
Profit after Tax (Net Income)	-172.61	-165.67	-80.60	-36.95	-34.18	-50.31
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-35.36	-50.64

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	127.38	78.09	171.81	81.72	110.90	64.41
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.75	2.96	4.06	4.71	4.80	5.41
Current Liabilities	34.17	64.80	24.36	9.51	10.71	8.85
Total Liabilities	199.47	145.84	200.23	95.94	126.41	78.67

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	4.63	3.82	4.92	5.76	5.67	6.46
Current Assets	160.67	142.02	195.30	90.18	120.74	72.20
Total Assets	199.47	145.84	200.23	95.94	126.41	78.67
Total Debt*	4.96	4.07	5.12	5.55	5.41	6.00
Net Current Assets	126.51	77.23	170.95	80.67	110.03	63.36

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-113.20	-70.76	-33.46	-27.57	-42.11
Cash Flow from Investing Activities	--	100.31	-85.39	33.35	-90.96	24.17
Cash from Financing Activities	--	65.09	161.88	0.03	75.26	19.89
Net Cash Inflow / Outflow	--	--	--	--	-43.27	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.01	-1.94	-1.26	-0.84	-1.42	-2.74
Cash EPS ($)	--	-1.94	-1.26	-0.83	-1.41	-2.73
Adjusted Book Value ($)	--	0.92	2.69	1.86	4.62	3.51
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.33	-1.11	-0.76	-1.15	-2.30
Free Cash Flow per Share ($)	--	-1.33	-1.12	-0.77	-1.15	-2.31

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-127.89	-61.02	-36.30	-36.61	-60.39
ROE (%)	-168.01	-132.59	-63.58	-38.36	-39.00	-65.29
ROA (%)	-91.79	-95.75	-54.43	-33.24	-33.34	-54.88
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-2,919.21	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-72.98	-105.54	-118.15	-1.16	27.62	-17.90
Net Profit Growth (%)	-72.98	-105.54	-118.15	-8.09	32.05	-18.86
EPS Growth (%)	-28.49	-0.54	-0.50	0.41	0.48	-0.04
Book Value Growth (%)	-34.49	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.96	-3.06	-5.41	-2.90	-3.93
Price / Book Value	3.22	4.16	1.44	2.44	0.89	3.07
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-4.13	-1.16	-0.85	-3.24	0.38	-2.67
Close Price ($)	3.05	3.81	3.87	4.55	4.13	10.79
High Price ($)	6.42	5.37	13.68	6.85	11.27	23.95
Low Price ($)	2.72	1.61	3.01	2.18	1.53	7.00
Market Cap ($ Cr)	397.87	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.05	0.03	0.07	0.05	0.09
Short term debt to equity ratio	0.01	0.01	0.01	0.01	0.01	0.01
Current Ratio	4.70	2.19	8.02	9.49	11.28	8.16
Quick Ratio	4.70	--	--	--	--	8.19
Interest Coverage	--	--	--	--	-114.86	-154.80

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	-279.31	-134.45
Payable days	--	3,986.44	2,128.90	1,743.45	2,246.56	2,405.50
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.